Chie‐Schin Shih

Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability–High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials

Joseph Chao, Charles S. Fuchs, Kohei Shitara et al. · JAMA Oncology · 2021 · 415 citations · Full text

Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial

Yelena Y. Janjigian, Akihito Kawazoe, Yuxian Bai et al. · The Lancet · 2023 · 390 citations

Her2-positive Gastric, Gastrointestinal Oncology, Interim Analyses +7

Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study

Kohei Shitara, Sun Young Rha, Lucjan Wyrwicz et al. · The Lancet Oncology · 2023 · 294 citations

Interim Analysis, Surgical Oncology, Oncology +8

Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial

Charles S. Fuchs, Mustafa Özgüroğlu, Yung‐Jue Bang et al. · Gastric Cancer · 2021 · 162 citations · Full text

Recommendations for imaging tumor response in neurofibromatosis clinical trials

Eva Dombi, Simone Ardern‐Holmes, Dusica Babovic‐Vuksanovic et al. · Neurology · 2013 · 139 citations · Full text